Cubist Systematic Strategies, LLC Aldeyra Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $19.3 Billion
  • Q3 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 101,375 shares of ALDX stock, worth $513,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,375
Previous 29,967 238.29%
Holding current value
$513,971
Previous $114,000 359.65%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$4.0 - $5.89 $285,632 - $420,593
71,408 Added 238.29%
101,375 $524,000
Q2 2025

Aug 14, 2025
BUY
$1.42 - $5.48 $42,553 - $164,219
29,967 New
29,967 $114,000
Q4 2023

Feb 14, 2024
SELL
$1.47 - $6.06 $4,108 - $16,937
-2,795 Reduced 18.72%
12,138 $42,000
Q3 2023

Nov 14, 2023
BUY
$6.11 - $8.16 $91,240 - $121,853
14,933 New
14,933 $99,000
Q1 2023

May 15, 2023
BUY
$5.77 - $9.93 $33,217 - $57,167
5,757 New
5,757 $57,000
Q3 2022

Nov 14, 2022
BUY
$3.8 - $7.74 $91,154 - $185,667
23,988 Added 25.99%
116,285 $621,000
Q3 2022

Nov 14, 2022
BUY
$3.8 - $7.74 $91,154 - $185,667
23,988 Added 25.99%
116,285 $621,000
Q2 2022

Aug 15, 2022
BUY
$2.43 - $4.85 $190,298 - $379,813
78,312 Added 559.97%
92,297 $368,000
Q1 2022

May 16, 2022
SELL
$3.25 - $5.17 $228,660 - $363,745
-70,357 Reduced 83.42%
13,985 $62,000
Q4 2021

Feb 14, 2022
BUY
$3.5 - $9.63 $143,815 - $395,696
41,090 Added 95.0%
84,342 $337,000
Q3 2021

Nov 15, 2021
SELL
$7.94 - $11.31 $616,120 - $877,622
-77,597 Reduced 64.21%
43,252 $380,000
Q2 2021

Aug 16, 2021
BUY
$10.44 - $14.85 $393,922 - $560,320
37,732 Added 45.4%
120,849 $1.37 Million
Q1 2021

May 17, 2021
BUY
$6.53 - $14.42 $384,355 - $848,761
58,860 Added 242.65%
83,117 $987,000
Q4 2020

Feb 16, 2021
BUY
$6.31 - $8.13 $145,773 - $187,819
23,102 Added 2000.17%
24,257 $166,000
Q3 2020

Nov 16, 2020
BUY
$4.0 - $7.53 $4,620 - $8,697
1,155 New
1,155 $9,000
Q1 2020

May 15, 2020
SELL
$1.62 - $6.4 $24,543 - $96,960
-15,150 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$4.73 - $7.98 $71,659 - $120,897
15,150 New
15,150 $88,000
Q3 2019

Nov 14, 2019
SELL
$4.41 - $6.12 $22,367 - $31,040
-5,072 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$6.0 - $9.0 $30,432 - $45,648
5,072 New
5,072 $30,000

Others Institutions Holding ALDX

# of Institutions
143
Shares Held
39.9M
Call Options Held
344K
Put Options Held
71.7K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $296M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email